Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut AllergyDavid M. Fleischer, Wayne G. Shreffler, Matthew Greenhawt et al.|JAMA|2019Cited by 271
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M. Fleischer, Hugh A. Sampson, Wayne G. Shreffler et al.|Journal of Allergy and Clinical Immunology|2020Cited by 101
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyBrian P. Vickery, Dareen Siri, Andrea Vereda et al.|The Journal of Allergy and Clinical Immunology In Practice|2020Cited by 89
Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) SurveyAlice Chan, M. Teresa de la Morena, Shanmuganathan Chandrakasan et al.|Frontiers in Immunology|2020Cited by 81
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial ResultsJacqueline A. Pongracic, Philippe Bégin, Rémi Gagnon et al.|The Journal of Allergy and Clinical Immunology In Practice|2021Cited by 61